About this episode

This episode discusses the efficacy of Tirofiban and dual antiplatelet therapy in improving neurological outcomes for stroke patients post-thrombolysis.

The JournalFeed podcast for the week of June 22-26, 2026. These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member. Thursday’s Spoon Feed : Tirofiban resulted in greater 90-day excellent neurological outcomes vs. placebo in patients with no medium or large vessel occlusion (LVO) who were not improving with with tenecteplase (TNK), NNT = 9. Friday’s Spoon Feed : Dual antiplatelet therapy (DAPT) with ticagrelor plus aspirin vs. placebo in patients with stroke treated with thrombolysis resulted in better 90-day excellent neurological outcome, NNT = 15, without a significant increase in symptomatic intracranial hemorrhage (sICH).

People in this episode

Host: Nick Zelt

Topics covered

• thrombolysis
• dual antiplatelet therapy
• neurological outcomes
• stroke treatment
• clinical trials

Mentioned in this episode

Organizations: JournalFeed

Products: Tirofiban, tenecteplase, ticagrelor, aspirin

More episodes of JournalFeed

• Hypothermia and Mortality | Switch The Kit? · July 18, 2026 · 11 min
• Early Pressors vs. Fluids | Bicarb For IHCA · July 11, 2026 · 11 min
• BB and CCB Toxicity | Fearing The Elderly Abdomen · July 4, 2026 · 14 min
• Chest Pain Stats | Private vs EMS · June 13, 2026 · 10 min
• 12mg for SVT | COACT at 5 Years · June 6, 2026 · 8 min

Explore listener stats, chart rankings, contacts and more on the JournalFeed podcast page.